New combination treatment offers hope for older patients with mantle cell lymphoma
The phase 2 trial PrE0405 met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients ...
Tag: Non-Hodgkin Lymphoma
POPULAR NEWS
The phase 2 trial PrE0405 met its primary endpoint, achieving a complete response (CR) rate of 85% in 33 patients ...
